Redesigning the end-to-end clinical onboarding workflow for a global biopharmaceutical company — replacing hand-signed fax forms with a digital platform that achieved a 98% first-time pass rate and eliminated missing-signature compliance incidents entirely.
A global biopharmaceutical client needed to digitise a fragmented, paper-based clinical onboarding process — reducing task completion time, eliminating compliance risk, and accelerating clinical trial activation across global sites. Each role required carefully controlled access, visibility, and permissions.
HCPs and Designees operated in what internal teams called the 'Paper Era'. Knowledge assessments were printed, signed by hand, and faxed with no confirmation of receipt. A 22% failure rate, zero status visibility, and persistent audit anxiety defined every trial activation cycle.
This wasn't a typical SaaS redesign. Every design decision operated under strict regulatory oversight. Rather than treating these as blockers, I reframed them as the design brief — each constraint became a feature the system had to make legible, not invisible.
All three roles share one navigation shell — but the content surface changes entirely based on who is authenticated. Pre-certification: Home, Resources, Contact Us only. Post-certification: My Patients, My Teams added. The nav itself signals completion status without any additional UI.
Before designing any screen, I mapped the full product scope as a working flow — distinguishing single-screen flows (blue) from multi-screen flows (pink). The My Teams branch — four dedicated sub-flows for Designee and Support Staff management — was the first structural evidence that the coordination layer warranted its own architectural layer.
Before wireframing a single screen, I mapped the full HCP & Designee journey across 5 phases. The pain points row became the direct input to the three insights that shaped the entire design direction.
The Knowledge Assessment was the highest-stakes interaction — a formal FDA-required test HCPs must pass before prescribing. Research Insight 3 shaped every iteration.
Every screen addresses a user anxiety mapped in the journey map. The annotations connect the design decision to the pain point that drove it.
In regulated enterprise UX, design decisions rarely live in a vacuum. When users asked "why can't I just fix a typo?" and Compliance said "signed records must remain immutable" — the conflict wasn't about permissions. It was about mental models of what 'editing' means in a regulated context.
All metrics compare the paper-based baseline against post-launch performance across a 3-month window.
"Good UX in regulated environments isn't about removing constraints — it's about making those constraints clear, trustworthy, and easy to work within. By aligning user needs, regulatory rigour, and technical constraints, this redesign delivered a platform that reduced compliance risk, accelerated trial activation, and gave healthcare providers genuine confidence in their most critical daily tasks."